AC
CTXR icon

Armistice Capital’s Citius Pharmaceuticals CTXR Stock Holding History

Armistice Capital’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-291,040
Closed -$3.64M – 255
2024
Q3 		$3.64M Sell
291,040
-115,200
-28% -$1.94M 0.06% 136
2024
Q2 		$5.93M Buy
+406,240
New +$7.28M 0.07% 108
2019
Q4 		– Sell
-87,895
Closed -$2.47M – 73
2019
Q3 		$2.47M Buy
+87,895
New +$2.32M 0.16% 59
2019
Q1 		– Sell
-29,537
Closed -$768K – 74
2018
Q4 		$768K Buy
29,537
+27,200
+1,164% +$931K 0.06% 62
2018
Q3 		$100K Buy
+2,337
New +$112K 0.01% 76

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Armistice Capital's CTXR Position: Q4 2024 in Review

Armistice Capital sold out of Citius Pharmaceuticals (CTXR) in Q4 2024, closing a stake of 291,040 shares — an estimated $3.64M sold.

Armistice Capital first reported a position in CTXR in Q3 2018 and held it in 5 quarters. The position peaked at $5.93M in Q2 2024. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

  • Armistice Capital reported no remaining Citius Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Armistice Capital sold 291,040 Citius Pharmaceuticals shares in Q4 2024, an estimated $3.64M.
  • Armistice Capital first reported a position in Citius Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Armistice Capital's Citius Pharmaceuticals position peaked at $5.93M in Q2 2024.
  • 30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.